EMERYVILLE, Calif., June 12 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX - News) today announced the appointment of Laura Brege as executive vice president and chief business officer. In this newly created position, Ms. Brege will be responsible for Finance, Business Development, Legal, Human Resources, and Investor Relations functions and will report to Hollings C. Renton, chairman, president, and chief executive officer of Onyx.
